Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Galmed Pharmaceuticals (GLMD)
NASDAQ:GLMD
Holding GLMD?
Track your performance easily
Galmed Pharmaceuticals (GLMD) Ownership Overview
6.20%
Insiders
1.24% Mutual Funds
<0.01% Other Institutional Investors
92.56% Public Companies and
Individual Investors
The ownership structure of Galmed Pharmaceuticals (GLMD) stock is a mix of institutional, retail, and individual investors. , 6.20% is owned by Insiders, and 92.56% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 317,504 | Insider | 6.20% | 889,011 | |
| 20,401 | Institution | 1.23% | 57,123 | |
| 151 | Institution | <0.01% | 423 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 20,401 | Institution | 1.23% | 57,123 | |
| 151 | Institution | <0.01% | 423 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Galmed Pharmaceuticals (GLMD)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 6.20% is held by insiders, and 92.56% is held by retail investors.
What percentage of Galmed Pharmaceuticals (GLMD) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Galmed Pharmaceuticals (GLMD) stock is held by institutional investors.
What percentage of Galmed Pharmaceuticals (GLMD) stock is held by retail investors?
According to the latest TipRanks data, approximately 92.56% of Galmed Pharmaceuticals (GLMD) stock is held by retail investors.
Who owns the most shares of Galmed Pharmaceuticals (GLMD)?
Allen Baharaff owns the most shares of Galmed Pharmaceuticals (GLMD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.